tm
Seeing Is Believing
tm
Seeing Is Believing
SLNO is currently covered by 7 analysts with an average price target of $82.58. This is a potential upside of $41.04 (98.8%) from yesterday's end of day stock price of $41.54.
Soleno Therapeutics's activity chart (see below) currently has 46 price targets and 49 ratings on display. The stock rating distribution of SLNO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 52.86% with an average time for these price targets to be met of 130.5 days.
Highest price target for SLNO is $145, Lowest price target is $105, average price target is $117.14.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 18-Aug-2025. First documented stock forecast 22-Jun-2018.
Currently out of the existing stock ratings of SLNO, 15 are a BUY (100%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 03-Sep-2024
$110
$67 (155.81%)
$100
4 months 26 days ago
(18-Aug-2025)
4/7 (57.14%)
$41.91 (61.55%)
121
Buy
Since 23-Dec-2019
$110
$67 (155.81%)
$105
5 months 6 days ago
(07-Aug-2025)
12/15 (80%)
$31.29 (39.75%)
221
Buy
Since 21-Nov-2023
$106
$63 (146.51%)
$97
5 months 6 days ago
(07-Aug-2025)
3/5 (60%)
$27.29 (34.67%)
50
Buy
Since 10-May-2024
$121
$78 (181.40%)
$105
6 months 2 days ago
(11-Jul-2025)
2/5 (40%)
$39.43 (48.34%)
224
Buy
Since 22-Jun-2018
$145
$102 (237.21%)
$93
8 months 20 days ago
(24-Apr-2025)
0/3 (0%)
$70.77 (95.34%)
What is SLNO (Soleno Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SLNO (Soleno Therapeutics) with a proven track record?
Which analyst has the current lower performing score on SLNO (Soleno Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SLNO (Soleno Therapeutics)?
Which analyst is the currently most bullish on SLNO (Soleno Therapeutics)?
Which analyst is the currently most reserved on SLNO (Soleno Therapeutics)?
